LIFE SCIENCESFORUM 2019

SEPTEMBER 18 CONVENE 810 SEVENTH AVE, NEW YORK

REGISTRATIONSregistrations@managingip.com

+44 (0) 207 779 8938

PROGRAMMEraf.oreilly@legalmediagroup.com

SPONSORSHIPmpetch@euromoneyplc.com

+44 (0) 207 779 8836

SPONSORS

FREE FOR

IN-HOUSE

COUNSEL

#MIPLIFESCIENCES

WWW.MANAGINGIP.COM/LIFESCIENCES

While AbbVie Inc. and Boehringer Ingelheim GmbH may well have finally settled their biosimilar dispute in relation to Humira, the world’s bestselling drug with $20 billion in global sales in 2018, the FDA’s recent approval of Samsung Bioepis’s Eticovo biosimilar was at the same time closely followed by the almost immediate launch of litigation by Amgen in response.

These two cases are surely representative of just how difficult and complex the current landscape for patent prosecution and litigation is right now in the biosimilars markets and beyond. What is certainly clear is that while the threats are huge, the opportunities have never been greater for those who get their patent prosecution, protection, litigation, and commercialization strategies right.

The fourth annual MIP Life Sciences Forum brings together leading industry players, including in-house and outside counsel, and members of the judiciary, to address the latest decisions and tumultuous changes affecting the life sciences industry today. By attending, you will be able to benchmark your practices against those of your peers, and understand what you need to do to take advantage of the considerable opportunities available, while at the same time protecting your patents and minimising your risk.

Book your place today.

OVERVIEW

VENUEConvene 810Seventh AveNew York

JOIN 100+ SENIOR IP PROFESSIONALS INCLUDING:

Heads/directors of IP Patent counsel/attorneys

IP in-house counsel & managers

Judges Private practice lawyers

Information was clearly presented, updates on the law and patent practice tips

Great panel chemistry and venue, interesting subject matter

Made for an intimate environment for high level networking

SEPTEMBER 18 LIFE SCIENCES FORUM 2019, CONVENE 810 SEVENTH AVE, NEW YORK

• Take a closer look at biologics

and expansion in the biosimilars arena

• Hear comprehensive coverage of the latest decisions and developments in the Supreme Court, PTAB and the Federal Circuit

• Assess the Canadian patent landscape

• Pinpoint the hot issues in international litigation; and

• Seek to understand what makes a successful partnership and commercial strategy currently

BENEFITS OFATTENDING

SEPTEMBER 18 LIFE SCIENCES FORUM 2019, CONVENE 810 SEVENTH AVE, NEW YORK

PROGRAMME

8.15 REGISTRATION AND COFFEE

9.00 OPENING REMARKS

Elizabeth Weiswasser, co-head, life sciences and patent litigation practices, Weil Stephanie Donahue, senior director, patent litigation, Sanofi

9.10 The latest developments in patent prosecution and exclusivity extension

• Avoiding prosecution pitfalls in developing pharmaceutical patent portfolios

• Strategies to manage and extend market exclusivity • Subject matter eligibility in life sciences – patenting

discoveries, diagnostics, and therapies that may be deemed ‘naturally occurring’ by a patent examiner

SPEAKERS

Carla Ji-Eun Kim, director, Sterne Kessler Goldstein & Fox (moderator) Leon Lum, senior intellectual property counsel, legal & corporate

affairs, Novo Nordisk Cara Lowen, vice president and chief patent counsel, Codiak BioSciences Brian Walsh, assistant general counsel - intellectual property, Bristol Myers Squibb

10.00 The current patent landscape in Canada – an essential update

• The latest developments in the Canadian patent landscape, including: • Subject matter issues • File history estoppel • Patent term extensions • Pricing of patented medicines in Canada • How might these developments influence your patent strategy

in Canada?

SPEAKERS

Jennifer Ledwell, associate, Marks & Clerk William Coppola, intellectual property counsel, Aerie Pharmaceuticals

10.30 NETWORKING COFFEE BREAK

10.50 Analysing the latest developments affecting PTAB IPRs • Orange Book patent/biologic patent study and district court

pharma litigation study • PTAB Precedential Opinion Panel (POP) • Second update to PTAB Trial Practice Guide • New pilot program for motions to amend

SPEAKERS

Michael Flibbert, partner, Finnegan (moderator) The Honorable Jacqueline Bonilla, deputy chief judge, Patent Trial and Appeal Board, U.S. Patent & Trademark Office Kristan Lansbery, director, patent attorney, Regeneron Pharmaceuticals William Raich, partner, Finnegan

11.40 US pharma litigation: annual review and trends • Recent developments in § 101 case law • Momenta, estoppel, and other IPR-related litigation • Patent term, PTA, and ODP

SPEAKERS

Keith Orso, partner, Irell & Manella Jill Schmidt, senior counsel, Genentech Ian Washburn, partner, Irell & Manella

12.30 NETWORKING LUNCH

13.20 Successful and practical strategies to adopt in cross-border litigation

This session highlights the particular problems posed by litigation in a cross-border context, and considers the strategies necessary to address and overcome these problems. Looking at real life instances and examples, delegates will gain an understanding of the best practices that need to be adopted to bring about a successful outcome.

SPEAKERS

Paul Inman, partner, Gowling WLG (moderator) Paul Coletti, associate patent counsel, Johnson & Johnson Ilya Goryachev, senior lawyer, Gorodissky

14.10 Misdeeds and major ramifications for patent litigation – a survey of recent case law relating to attorney’s fees and consequences of bad behavior during dealmaking, prosecution and litigation

This topic offers practical advice for prosecutors and litigators, along with a discussion of the tools available to remedy mistakes made or uncovered during diligence, and looks to answer key questions including:

• What types of litigation tactics are courts finding “exceptional” in the context of biopharmaceutical patent litigation?

• How can deal diligence upend a positive litigation outcome? • How can litigation behavior taint in-house counsel patent

prosecution efforts? • How are companies evaluating and managing potentially

inappropriate activities during patent prosecution?

SPEAKERS

Filko Prugo, partner, Ropes & Gray Charlotte Jacobsen, partner, Ropes & Gray

15.00 NETWORKING COFFEE BREAK

15.20 Litigation management – best practice tips for successful collaborations

This session will look at the challenges involved in coordinating a successful litigation strategy. Looking from an in-house counsel perspective, delegates will gain an understanding of how best to prepare and work with outside counsel, including the matters that can be dealt with internally and what would be better outsourced

SPEAKERS

Elizabeth Weiswasser, co-head, life sciences and patent litigation practices, Weil Stephanie Donahue, senior director, patent litigation, Sanofi Chloe Jiang, intellectual property counsel, Novo Nordisk Abigail Langsam, counsel, Arnold & Porter

16.10 An essential guide to commercialising your IP • What are the main partnering issues to consider between

large and small organizations? • Working with competitors • Investment - how to deal with funding from life sciences

companies, whether US or from abroad, and funding from other sources (like NIH)

SPEAKERS

Chad Davis, partner, Dechert Gloria Fuentes, executive director, corporate transactions, Merck Michael Brignati, associate general counsel, Penn State University Shaun Ryan, deputy general counsel, Moderna Therapeutics Tom Rayski, partner, Dechert

17.00 CHAIR’S CLOSING REMARKS AND CONFERENCE ENDS

BOOKING FORM

YOUR DETAILS FOR REGISTRATION (PLEASE PRINT)

Delegate

Name:

Job title:

Company:

Address:

Postcode:

Country:

Tel:

Email:

Please photocopy this page if registering more than one delegate

TO REGISTER

Telephone

+44 (0) 20 7779 8938

Email

registrations@managingip.com

METHOD OF PAYMENT

Please tick the appropriate box to choose your payment method and sign below:

Bank transfer (details will be provided by invoice)

Credit card payment (pay online at www.managingip.com/MIPlifesciences or call +44 (0) 207 779 8811)

REGISTRATION: All registrations are subject to final review. Where the registration fee applies, the

fee is charged in EUR

PAYMENT: All registration fees (where applicable) must be received in full prior to the invoice due

date or event date, whichever is sooner.

Please note that in completing this booking form you undertake to adhere to the cancellation and

payment terms listed on this form.

Signature: Date:

Position:

IP/patent in-house counsel, heads of legal

Law firms, IP service providers and consultancies

Early bird rate (before August 2)

FREE $795

Standard rate (after August 2)

FREE $1095

© Legal Media Group 2019

CANCELLATION POLICY: By registering for an event, you are agreeing to the terms and conditions whereby you are liable for a cancellation fee or the full conference fee (and field trip, pre/post conference workshops).

FREE DELEGATES:By registering for an event, you are agreeing to the terms and conditions whereby you are liable for a can-cellation fee of $199 if you cancel less than 48 hours before the event. All cancellations must be received in writing no later than September 16 2019. We cannot accept verbal cancellations. Cancellations received after September 16 2019 are liable for the $199 fee.

PAYING DELEGATES: By registering for an event, you are agreeing to the terms and conditions where by you are liable for the full conference fee. All cancellations must be received in writing no later than 6 weeks before the first day of the event (August 8 2019) for a full refund less a 10% administration charge. We cannot accept verbal cancellations. Cancellations received after August 8 2019 are liable for the full conference fee. However, substitutions can be sent to attend in your place at no extra charge.

If owing to a force majeure, Managing IP is obliged to postpone or cancel the event Managing IP will not be liable for any travel or accommodation expenses incurred by delegates or their organisations. Badge swapping with other registered/non-registered delegates is against our company policy and will not be permitted.

MARKETING PREFERENCES I agree to receive exclusive news, content and offers from Managing IP and other Euromoney group compa-ny products and services by:• Email • Telephone • Mail • Third party (sponsors only)

You can unsubscribe at any time by clicking the “un-subscribe” link at the bottom of any communications we send you. You can also visit our preference centre and Privacy Notice.

FINANCIAL AID POLICYPlease refer to our website for the details on full or partial scholarship available for lawyers and law students experiences financial hardships.https://www.managingip.com/stub.aspx?stubid=34977

SEPTEMBER 18 LIFE SCIENCES FORUM 2019, CONVENE 810 SEVENTH AVE, NEW YORK